Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Jansen

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2011
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulationSwenja Schuhmacher, Marc Foretz, Maike Knorr, et al.
Pharmacology|June 14, 2014
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazoneMaike Knorr, Michael Hausding, Amanda Pfeffer, et al.
Pharmacology|October 9, 2017
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and ValsartanMatthias Oelze, Philipp Welschof, Maike Knorr, et al.
Hypertension (Dallas, Tex. : 1979)|February 17, 2010
Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1Swenja Schuhmacher, Philip Wenzel, Eberhard Schulz, et al.
Cardiovascular Research|July 9, 2018
α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunctionThomas Jansen, Swenja Kröller-Schön, Tanja Schönfelder, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 28, 2013
Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic ratsHanke Mollnau, Matthias Oelze, Elena Zinßius, et al.
Plos One|November 18, 2014
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityMatthias Oelze, Swenja Kröller-Schön, Philipp Welschof, et al.
Basic Research in Cardiology|January 16, 2019
Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunctionSwenja Kröller-Schön, Thomas Jansen, Thi Lan P Tran, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 2, 2022
Scaling and Confinement in Ultrathin Chalcogenide Films as Exemplified by GeTePeter Kerres, Yiming Zhou, Hetal Vaishnav, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2011
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulationSwenja Schuhmacher, Marc Foretz, Maike Knorr, et al.
Pharmacology|June 14, 2014
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazoneMaike Knorr, Michael Hausding, Amanda Pfeffer, et al.
Pharmacology|October 9, 2017
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and ValsartanMatthias Oelze, Philipp Welschof, Maike Knorr, et al.
Hypertension (Dallas, Tex. : 1979)|February 17, 2010
Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1Swenja Schuhmacher, Philip Wenzel, Eberhard Schulz, et al.
Cardiovascular Research|July 9, 2018
α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunctionThomas Jansen, Swenja Kröller-Schön, Tanja Schönfelder, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 28, 2013
Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic ratsHanke Mollnau, Matthias Oelze, Elena Zinßius, et al.
Plos One|November 18, 2014
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityMatthias Oelze, Swenja Kröller-Schön, Philipp Welschof, et al.
Basic Research in Cardiology|January 16, 2019
Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunctionSwenja Kröller-Schön, Thomas Jansen, Thi Lan P Tran, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 2, 2022
Scaling and Confinement in Ultrathin Chalcogenide Films as Exemplified by GeTePeter Kerres, Yiming Zhou, Hetal Vaishnav, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Pageof 15